Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.

MLA

Shabani, Samaneh H., et al. “Biological, Immunological and Functional Properties of Two Novel Multi-Variant Chimeric Recombinant Proteins of CSP Antigens for Vaccine Development against Plasmodium Vivax Infection.” Molecular Immunology, vol. 90, Oct. 2017, pp. 158–71. EBSCOhost, https://doi.org/10.1016/j.molimm.2017.06.033.

APA

Shabani, S. H., Zakeri, S., Salmanian, A. H., Amani, J., Mehrizi, A. A., Snounou, G., Nosten, F., Andolina, C., Mourtazavi, Y., & Djadid, N. D. (2017). Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection. Molecular Immunology, 90, 158–171. https://doi.org/10.1016/j.molimm.2017.06.033

Chicago

Shabani, Samaneh H., Sedigheh Zakeri, Ali H. Salmanian, Jafar Amani, Akram A. Mehrizi, Georges Snounou, François Nosten, Chiara Andolina, Yousef Mourtazavi, and Navid D. Djadid. 2017. “Biological, Immunological and Functional Properties of Two Novel Multi-Variant Chimeric Recombinant Proteins of CSP Antigens for Vaccine Development against Plasmodium Vivax Infection.” Molecular Immunology 90 (October): 158–71. doi:10.1016/j.molimm.2017.06.033.